The Best CDI Software 2026: Top 10 Clinical Documentation Integrity Vendors, Ranked

On 27 August 2026, ACDIS and AHIMA published a new edition of the Guidelines for Achieving a Compliant Query Practice. It supersedes every previous version including 2022, applies across inpatient, outpatient, ambulatory and professional fee settings, and contains a section that did not exist before.^[1][2] Section XI governs query technology, and it is written broadly on purpose: computer-assisted physician documentation running live in an encounter, computer-assisted coding surfacing post-encounter opportunities, large language models and generative AI drafting query language, and EHR-integrated advisories and alerts are all in scope.

The definitional move is the important one. A communication counts as a query when it presents a provider with a specific diagnosis or documentation option for consideration in connection with a specific patient encounter, regardless of what the vendor calls it or where it appears in the interface. A nudge is a query. An advisory is a query. A pop-up suggesting a more specific diagnosis is a query. Passive decision support that surfaces reference information without directing the provider toward a specific response is not — and when in doubt, the brief says treat it as one. A large amount of software that has been sold as documentation assistance is now explicitly inside a compliance regime it was not designed for.^[1]

Two consequences shape this guide. The first is that query construction stopped being a soft differentiator. Five standards now apply to technology-generated queries, they are testable against any output, and they form the benchmark for technology-generated query compliance — with a worked comparison against EvidenceMD's actual output further down the page. The second is a warning aimed directly at procurement: organisations should not assume that a vendor-supplied or EHR-integrated tool produces compliant queries by default, and query professionals and compliance leaders must be involved in evaluating, configuring and monitoring anything that generates queries. Accountability for every query delivered to a provider stays with the organisation, including AI-assisted ones, and where there is no pre-delivery human review the brief expects structured auditing of the output on a regular basis.^[1]

Section XI also names the failure mode it is worried about, and it is not incompetence. It is that tool configuration, training data or system design can introduce directional bias, or prioritise reimbursement outcomes over clinical accuracy. That is a precise description of what happens when a CDI product is optimised for revenue lift, and it is the reason this guide treats auditability as decisive. A finding you can trace to the words in the chart is a finding you can defend. A confidence score is not.^[1]

DRG capture comes down to one thing far more often than it comes down to anything else: a complication or comorbidity that was clinically present, evidenced in the chart, and never written down as a diagnosis. The vitals are there. The labs are there. The treatment is there. The words are not, so the case groups without it, and the severity-of-illness and risk-of-mortality scores understate how sick the patient was — which affects the published mortality index as well as the payment.

On inpatient notes the standalone workspace returns a dedicated DRG Impact section built around exactly that problem. It identifies the principal diagnosis, classifies the secondary diagnoses that already function as a CC or MCC, and then does the part that matters: it lists query opportunities for unstated CC and MCC conditions, each one carrying the clinical indicators quoted verbatim from the note, a non-leading query drafted around those indicators, the neutrality line, and the direction of the severity effect described qualitatively — CC to MCC movement, or SOI and ROM capture. It closes with a one-sentence DRG bottom line.

Consider a classic inpatient DRG scenario: A patient with acute gallstone pancreatitis, a heart rate of 94, a white count of 12.3 and 29% bands, and a note that describes a significant acute inflammatory response without ever naming it. Those values meet SIRS criteria, and non-infectious SIRS coded as R65.10 is a CC as a secondary diagnosis.^[8] Unstated, the case groups without it. The distance between those two outcomes is one sentence in an addendum, and finding it requires recognising a pattern across four separate data points rather than matching a phrase.

What EvidenceMD deliberately will not do is quote you an MS-DRG number, a relative weight or an APR-DRG code. It has no access to your payer mix, your base rate or your grouper version, and the instruction in the product is explicit: never fabricate them. That is a clear boundary against Solventum and Optum, which do model the financial delta and support APR-DRG, SOI and ROM natively. It is also the right failure mode: a fabricated dollar figure is worse than no dollar figure, because a CFO or auditor will act on it.

Most denials are not coverage disputes. They are documentation failures, which is why prevention beats appeal on economics before you get anywhere near clinical quality. CMS attributes 51.5% of Medicare fee-for-service improper payments to insufficient documentation, with medical necessity a further 17.8%, no documentation 11.7% and incorrect coding 10.8% — against an overall improper payment rate of 6.55% and $28.83 billion for FY2025.^[3][4] The commercial pattern says the same thing from a different angle: initial denial rates run roughly four times higher than final denial rates, precisely because so many denials evaporate once the documentation is produced.

The cost of that gap is measurable. Premier's national survey put the administrative cost of fighting a single denied claim at $57.23, up from $43.84 the year before, with labour accounting for 90% of the expense — and roughly 70% of denials ultimately overturned and paid, which means the large majority of that spend is argument about claims that should have been paid on submission.^[5] Kodiak's benchmarking across more than 2,300 hospitals found net revenue leakage from final denials and bad debt rose 25% in a single year, from $38.6 billion to $48.4 billion in 2025 — and attributed nearly the whole increase to clinical denials, meaning prior authorisation and medical necessity rather than coding mechanics.^[6]

EvidenceMD addresses the documentation share of that through a Denial Risk Flags section that only appears when there is something to flag — no empty headings, which matters more than it sounds when a specialist is reading forty of these. It looks for medical necessity that is not stated for an ordered test, a procedure documented without its indication, medications charted with no supporting diagnosis, copy-forward text that contradicts the current encounter, and elements missing for the note type. A separate billing pass covers the coding side: E/M level scored against the 2-of-3 rule, G2211 eligibility, charge capture for services documented but never billed, and modifier advisories such as modifier 25 on an E/M with a same-day procedure.

For the denials that come from level of care rather than coding, the standalone workspace argues inpatient against observation explicitly. Severity of illness and intensity of service are worked through criterion by criterion — each marked met, not met, or unknown, with unknowns named rather than assumed — and tested against the CMS Two-Midnight Rule at 42 CFR 412.3, matching the physician's expectation of stay length to the benefit category.^[7] It then drafts a medical necessity paragraph for the utilisation management record in the language a reviewer expects to read. It applies that logic as a reasoning framework and does not reproduce proprietary MCG or InterQual criteria text.

The honest limit: this addresses documentation and medical necessity denials, which is the largest category but not the only one. EvidenceMD does not scrub claims against payer-specific edit libraries or NCCI edits, so bundling and modifier denials are outside what it catches. RapidClaims and SmarterDx are built for that lane. Split your denials by cause before you decide which problem you are actually buying a solution to.

Buying an ambient scribe and a CDI platform gets you two systems that meet at a file boundary. The scribe produces a note, the CDI platform reads it some hours or days later, and everything between those two events is a workflow you have to run. A scribe with CDI reasoning is a different thing: the same system writes the note and reasons about whether it is defensible, in the same session, while the clinician is still in front of it.

In EvidenceMD that loop is four steps. The scribe drafts the note from the encounter. The integrity pass runs over that draft on request. Accepted findings are written back into the note in one click, with the untouched sections preserved bit for bit rather than regenerated. And there is one-click revert when the clinician disagrees, which is the step that decides whether clinicians actually use it. Where the patient is linked, up to five prior visits are pulled in, so chronic conditions coded at an earlier encounter but never addressed today surface for HCC recapture under CMS-HCC V28 — the recapture failure that quietly costs risk- adjusted programmes more than any single missed code.

The argument for that sequencing is economic rather than aesthetic. The same missing diagnosis costs a sentence before signature, or a query and a four-day wait during the admission, or a coder holding a claim pre-bill, or $57.23 and an appeal after the denial arrives.^[5] Every step to the right in that sequence costs more and succeeds less often, and query response rates are never 100%. Closing the gap in the authoring surface removes the encounter from the query economy entirely.

Two caveats. This only applies where the clinician is using EvidenceMD as their scribe — in the standalone workspace you are reviewing a note after the fact like any other tool, and apply-fix is not offered there. And Ambience Healthcare does this better at enterprise scale. It is the only other vendor here with native point-of-care capture, and the more deeply embedded of the two, because it is genuinely ambient and writes into Epic and Cerner over native FHIR rather than working on a note you bring it — a real gap, and one no output quality closes.

Every tool in this guide produces a draft, and the organisation owns everything that follows. That is not a disclaimer, it is the explicit position of the governing standard: humans remain responsible for query compliance even when technology generates the query, process owners retain accountability for every query delivered to a provider including AI-assisted ones, and where there is no pre-delivery human review, structured auditing of the output should run on a regular schedule.^[1] Staff must also be trained on the specific capabilities and limitations of the tool, and query professionals must stay able to distinguish a legitimate opportunity from an inappropriate trigger.

Four checks carry most of the practical risk. Confirm that every clinical indicator in a generated query traces to a specific place in this encounter's record rather than to something the model inferred — an indicator with no location is the clearest red flag in the 2026 brief. Check that no provider-visible label names a target diagnosis, a reimbursement impact or a quality measure; a tracking tag reading “CC/MCC opportunity” is non-compliant on its face. Verify that answer options always leave a route to Other and Clinically undetermined rather than offering only the revenue-favourable path. And make sure no follow-up query fires on a condition the physician already declined unless new clinical evidence has appeared.

Do not use a MEAT element count as your support test, and do not treat vendor certification as compliance evidence. The brief is direct that organisations should not assume a vendor-supplied or EHR-integrated tool produces compliant queries by default, and it expects query professionals and compliance leaders to be involved in evaluating, configuring and monitoring the technology. Write the policy: vendor vetting, human review process, audit frequency and methodology specific to technology-generated output, training requirements, and a route for reporting and correcting a non-compliant generated query.^[1]

On confidentiality, treat any CDI tool as a system processing protected health information and confirm the Business Associate Agreement covers the exact plan tier you are on rather than assuming plan-level coverage — that is where most compliance gaps in this category actually sit. Check encryption at rest and in transit, audit logging of PHI processing, retention terms, and whether the vendor's public privacy policy or the customer agreement governs your data, because for several vendors here they are different documents saying different things.